longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

XJZY

002332

8.520.24% ( +0.02 )
Delay Closed: Sep 16, 15:00:00
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

XJZY (002332)

Zhejiang Xianju Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid raw materials an...

Open
8.53
High
8.54
Low
8.45
Prev. Close
8.50
Volume
76.81K
Turnover
65.24M
Avg Price
8.49
Bid/Ask Ratio
--
Amplitude
1.06%
52wk High
9.98
Volume Ratio
0.37
Turnover Ratio
0.78%
52wk Low
7.82
Float Mkt Cap
8.43B
Market CapCNY
8.43B
P/ETTM
21.84
P/EDynamic
17.23
P/EStatic
--
EPSTTM
0.390
EPSDynamic
0.494
EPSStatic
--
BVPS
6.03
P/B
1.41
Circulating Supply
989.20M
Dividend YieldTTM
4.67%
DividendTTM
0.40
Shares
989.20M
Min lot size
100
Currency
CNY

XJZY Analyst Rating

View more

Forecast & Rating

Sep 11, 2026
Price forecast
¥11.3533.16%
Forecast & RatingStrong buy
2analysts
  • Strong buy100.00%
  • Buy0.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%
Strong buy
2
Buy
0
Hold
0
Sell
0
Strong sell
0

News

  • Zhitong · Oct 29, 2025 at 04:04 AM

    XJZY: Injectable Vecuronium Bromide is expected to be selected for centralized procurement

  • Zhitong · Oct 13, 2025 at 09:19 AM

    XJZY: Acetate Dexamethasone Tablets 0.5mg specification passed the consistency evaluation

  • Zhitong · Sep 19, 2025 at 09:49 AM

    XJZY obtained the domestic production drug registration certificate for estradiol tablets

  • Zhitong · Sep 19, 2025 at 07:49 AM

    XJZY and related personnel received a warning letter from the Zhejiang Securities Regulatory Bureau

  • Zhitong · Aug 22, 2025 at 08:41 AM

    XJZY: The company's dexamethasone acetate tablets have passed the consistency evaluation of generic drugs

  • Zhitong · Jul 11, 2025 at 07:45 AM

    XJZY: The drug registration application for tiotropium bromide inhalation aerosol has been accepted